Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-1988 | 03-1987 | 03-1986 | 03-1985 | 03-1984 | |
| Sales | 478 | 335 | 183 | 144 | 34 |
| Cost of Goods | 338 | 322 | 366 | 303 | 197 |
| Gross Profit | 140 | 14 | -183 | -159 | -163 |
| Operating Expenses | 343 | 610 | 840 | 1,338 | 1,060 |
| Operating Income | -202 | -596 | -1,023 | -1,497 | -1,222 |
| Interest Expense | 0 | 0 | 0 | 2 | 1 |
| Other Income | 3 | 17 | 75 | 207 | 215 |
| Pre-tax Income | -199 | -579 | -948 | -1,292 | -1,009 |
| Net Income Continuous | -199 | -579 | -948 | -1,292 | -1,009 |
| Net Income | $-200 | $-579 | $-949 | $-1,292 | $-1,009 |
| EPS Basic Total Ops | -0.04 | -0.12 | -0.20 | -0.27 | -0.21 |
| EPS Basic Continuous Ops | -0.04 | -0.12 | -0.20 | -0.27 | -0.21 |
| EPS Diluted Total Ops | -0.04 | -0.12 | -0.20 | -0.27 | -0.21 |
| EPS Diluted Continuous Ops | -0.04 | -0.12 | -0.20 | -0.27 | -0.21 |
| EBITDA(a) | $-169 | $-496 | $-926 | $-1,422 | $-1,222 |